Compare ELTX & PEBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELTX | PEBK |
|---|---|---|
| Founded | 2011 | 1912 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.1M | 157.0M |
| IPO Year | 2014 | 2012 |
| Metric | ELTX | PEBK |
|---|---|---|
| Price | $11.79 | $37.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 138.3K | 14.9K |
| Earning Date | 01-01-0001 | 04-27-2026 |
| Dividend Yield | N/A | ★ 2.56% |
| EPS Growth | ★ 38.94 | 7.58 |
| EPS | N/A | ★ 2.41 |
| Revenue | ★ $2,301,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.68 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.60 | $23.96 |
| 52 Week High | $14.93 | $40.74 |
| Indicator | ELTX | PEBK |
|---|---|---|
| Relative Strength Index (RSI) | 58.80 | 43.81 |
| Support Level | $7.78 | $35.24 |
| Resistance Level | $12.52 | $38.03 |
| Average True Range (ATR) | 1.12 | 0.96 |
| MACD | 0.05 | -0.26 |
| Stochastic Oscillator | 51.27 | 20.99 |
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.